← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Schedule 1 Therapeutics, Inc.
Chicago, IL
$3,192,104
Total funding
2
Grants
Funding over time
peak $2M · FY2020–25$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,192,104 · 2
By mechanism
R44$2,883,639 · 1
R41$308,465 · 1
Investigators at Schedule 1 Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics$2,019,222
R44 · FY2024 · DA
Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics$864,417
R44 · FY2025 · DA
Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics$308,465
R41 · FY2020 · DA